tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

AU:IMU Stock Latest News

Imugene Reports Key Milestones in Cancer Trials and Financial Strengthening
Company AnnouncementsImugene Reports Key Milestones in Cancer Trials and Financial Strengthening
9m ago
Imugene Limited Adjusts Securities Portfolio with Cessation of Restricted Stock Units
PremiumCompany Announcements
Imugene Limited Adjusts Securities Portfolio with Cessation of Restricted Stock Units
2d ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces Quotation of New Securities on ASX
2d ago
Imugene Secures A$20 Million to Advance Clinical Trials
PremiumCompany Announcements
Imugene Secures A$20 Million to Advance Clinical Trials
2d ago
Imugene Limited Issues Convertible Notes and Warrants to Fund Cancer Immunotherapy Efforts
PremiumCompany Announcements
Imugene Limited Issues Convertible Notes and Warrants to Fund Cancer Immunotherapy Efforts
3d ago
Imugene Releases Shares from Voluntary Escrow
PremiumCompany AnnouncementsImugene Releases Shares from Voluntary Escrow
7d ago
Imugene Secures $46 Million Investment to Boost Clinical Trials
Premium
Company Announcements
Imugene Secures $46 Million Investment to Boost Clinical Trials
7d ago
Imugene Limited Issues Unquoted Equity Securities for Employee Incentive
Premium
Company Announcements
Imugene Limited Issues Unquoted Equity Securities for Employee Incentive
7d ago
Imugene Limited Successfully Passes All Resolutions at Extraordinary General Meeting
PremiumCompany Announcements
Imugene Limited Successfully Passes All Resolutions at Extraordinary General Meeting
9d ago
Imugene Limited Announces Progress Amidst Strong Financial Standing
PremiumCompany Announcements
Imugene Limited Announces Progress Amidst Strong Financial Standing
9d ago
Imugene Limited Announces New Securities Quotation on ASX
PremiumCompany Announcements
Imugene Limited Announces New Securities Quotation on ASX
21d ago
Imugene Secures $11.7m R&D Tax Refund to Boost Cancer Therapy Development
PremiumCompany Announcements
Imugene Secures $11.7m R&D Tax Refund to Boost Cancer Therapy Development
21d ago
Imugene’s Australian Trial for Innovative Cancer Therapy Begins
PremiumCompany AnnouncementsImugene’s Australian Trial for Innovative Cancer Therapy Begins
28d ago
Imugene Secures A$46 Million for Clinical Trials
Premium
Company Announcements
Imugene Secures A$46 Million for Clinical Trials
1M ago
Imugene’s Azer-cel to be Featured at Major Conference
Premium
Company Announcements
Imugene’s Azer-cel to be Featured at Major Conference
1M ago
Imugene Limited Secures $11 Million R&D Tax Refund
PremiumCompany Announcements
Imugene Limited Secures $11 Million R&D Tax Refund
1M ago
Imugene Limited Updates and Focus on Cancer Therapies
PremiumCompany Announcements
Imugene Limited Updates and Focus on Cancer Therapies
2M ago
Imugene Limited Announces Director Change and Stock Holdings
PremiumCompany Announcements
Imugene Limited Announces Director Change and Stock Holdings
2M ago
Imugene Announces Board Changes Amid Cancer Therapy Focus
PremiumCompany Announcements
Imugene Announces Board Changes Amid Cancer Therapy Focus
3M ago
Imugene Limited Advances Amidst AGM Vote Challenges
PremiumCompany AnnouncementsImugene Limited Advances Amidst AGM Vote Challenges
3M ago
Imugene Limited: Leading Innovation in Cancer Treatment
Premium
Company Announcements
Imugene Limited: Leading Innovation in Cancer Treatment
3M ago
Imugene Limited Begins Innovative Cancer Trial
Premium
Company Announcements
Imugene Limited Begins Innovative Cancer Trial
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >